Evaluation of the in vitro biodegradation and biological behavior of poly(lactic- co -glycolic acid)/nano-fluorhydroxyapatite composite microsphere-sintered scaffold for bone tissue engineering
Restricted accessResearch articleFirst published online March, 2018
Evaluation of the in vitro biodegradation and biological behavior of poly(lactic- co -glycolic acid)/nano-fluorhydroxyapatite composite microsphere-sintered scaffold for bone tissue engineering
The objective of this research was to study the degradation and biological characteristics of the three-dimensional porous composite scaffold made of poly(lactic-co-glycolic acid)/nano-fluorhydroxyapatite microsphere using sintering method for potential bone tissue engineering. Our previous experimental results demonstrated that poly(lactic-co-glycolic acid)/nano-fluorhydroxyapatite composite scaffold with a ratio of 4:1 sintered at 90ºC for 2 h has the greatest mechanical properties and a proper pore structure for bone repair applications. The weight loss percentage of both poly(lactic-co-glycolic acid)/nano-fluorhydroxyapatite and poly(lactic-co-glycolic acid) scaffolds demonstrated a monotonic trend with increasing degradation time, that is, the incorporation of nano-fluorhydroxyapatite into polymeric scaffold could lead to weight loss in comparison with that of pure poly(lactic-co-glycolic acid). The pH change for composite scaffolds showed that there was a slight decrease until 2 weeks after immersion in simulated body fluid, followed by a significant increase in the pH of simulated body fluid without a scaffold at the end of immersion time. The mechanical properties of composite scaffold were higher than that of poly(lactic-co-glycolic acid) scaffold at total time of incubation in simulated body fluid; however, it should be noted that the incorporation of nano-fluorhydroxyapatite into composite scaffold leads to decline in the relatively significant mechanical strength and modulus during hydrolytic degradation. In addition, MTT assay and alkaline phosphatase activity results defined that a general trend of increasing cell viability was seen for poly(lactic-co-glycolic acid)/nano-fluorhydroxyapatite scaffold sintered by time when compared to control group. Eventually, experimental results exhibited poly(lactic-co-glycolic acid)/nano-fluorhydroxyapatite microsphere-sintered scaffold is a promising scaffold for bone repair.
MozafariMMoztarzadehFRabieeM. Development of 3D bioactive nanocomposite scaffolds made from gelatin and nano bioactive glass for biomedical applications. Adv Compos Lett2010; 19(2): 91–96.
2.
BlakerJJMaquetVJeromeR. Mechanical properties of highly porous PDLLA/bioglass composite foams as scaffolds for bone tissue engineering. Acta Biomater2005; 1(6): 643–652.
3.
FatehiKMoztarzadehFSolati-HashjinM. In vitro biomimetic deposition of apatite on alkaline and heat treated Ti6A14V alloy surface. B Mater Sci2008; 31(2): 101–108.
4.
MasaeliRKashiTJDinarvandR. Efficacy of calcium phosphate cement enhanced with 3wt%-nanostrontium-hydroxyapatite, and nanostrontium-CPC-incorporated simvastatin-loaded poly (lactic-co-glycolic-acid) microspheres in bone formation: an explorative multi-phase experimental in-vitro/in-vivo study. Mater Sci Eng C2016; 69(1): 171–183.
5.
Naghavi AlhosseiniSMoztarzadehFKargozarS. Development of polyvinyl alcohol fibrous biodegradable scaffolds for nerve tissue engineering applications: in vitro study. Int J Polym Mater Po2015; 64(9): 474–480.
6.
Sharifi SedehEMirdamadiSSharifianjaziF. Synthesis and evaluation of mechanical and biological properties of scaffold prepared from Ti and Mg with different volume percent. Synth React Inorg M2015; 45(7): 1087–1091.
7.
NajafabadiSAAKeshvariHSarkhoshH. Surface modification of castor oil-based polyurethane by polyacrylic acid graft using a two-step plasma treatment for biomedical applications. Adv Polym Tech2014; 33(3): 1–8.
8.
RazMMoztarzadehFShokrgozarMA. Development of biomimetic gelatin–chitosan/hydroxyapatite nanocomposite via double diffusion method for biomedical applications. Int J Mater Res2014; 105(5): 493–501.
9.
TouriRMoztarzadehFSadeghianZ. The use of carbon nanotubes to reinforce 45S5 bioglass-based scaffolds for tissue engineering applications. BioMed Res Int2013; 2013: 1–8.
10.
ZamaniYRabieeMShokrgozarMA. Response of human mesenchymal stem cells to patterned and randomly oriented poly (vinyl alcohol) nano-fibrous scaffolds surface-modified with Arg-Gly-Asp (RGD) ligand. Appl Biochem Biotechnol2013; 171(6): 1513–1524.
11.
HooshmandTAbrishamchianANajafiF. Development of sol-gel-derived multi-wall carbon nanotube/hydroxyapatite nanocomposite powders for bone substitution. J Compos Mater2013; 48(4): 483–489.
12.
Haghbin-NazarpakMMoztarzadehFSolati-HashjinM. Injectable and bioresorbable calcium phosphate delivery system with gentamicin sulphate for treatment of bone diseases: in vitro study. Adv Appl Ceram2011; 110(8): 482–489.
13.
BizariDMoztarzadehFRabieeM. Development of biphasic hydroxyapatite/dicalcium phosphate dihydrate (DCPD) bone graft using polyurethane foam template: in vitro and in vivo study. Adv Appl Ceram2011; 110(7): 417–425.
14.
KabiriMEmamiSHRafiniaM. Preparation and characterization of absorbable hemostat crosslinked gelatin sponges for surgical applications. Curr Appl Phys2011; 11(3): 457–461.
15.
Manavi-TehraniIRabieeMParvizM. Characterization and controlled release investigation of biocompatible pH-sensitive PVA/PAA hydrogels. Macromol Symp2010; 296(1): 457–465.
16.
NojehdehianHMoztarzadehFBaharvandH. Effect of poly-L-lysine coating on retinoic acid-loaded PLGA microspheres in the differentiation of carcinoma stem cells into neural cells. Int J Artif Organs2010; 33(10): 721–730.
17.
EmamiSHAbadAMABonakdarS. Preparation and evaluation of chitosan-gelatin composite scaffolds modified with chondroitin-6-sulphate. Int J Mater Res2010; 101(10): 1281–1285.
18.
RouhaniPSalahinejadEKaulR. Nanostructured zirconium titanate fibers prepared by particulate sol–gel and cellulose templating techniques. J Alloy Compd2013; 568: 102–105.
19.
SalahinejadEHadianfardMMacdonaldD. Aqueous sol–gel synthesis of zirconium titanate (ZrTiO4) nanoparticles using chloride precursors. Ceram Int2012; 38(8): 6145–6149.
20.
RazaviMFathiMSavabiO. Biodegradable magnesium alloy coated by fluoridated hydroxyapatite using MAO/EPD technique. Surf Eng2014; 30(8): 545–551.
21.
YazdimamaghaniMVashaeeDAssefaS. Green synthesis of a new gelatin-based antimicrobial scaffold for tissue engineering. Mater Sci Eng C2014; 39: 235–244.
22.
AshuriMMoztarzadehFNezafatiN. Development of a composite based on hydroxyapatite and magnesium and zinc-containing sol–gel-derived bioactive glass for bone substitute applications. Mater Sci Eng C2012; 32(8): 2330–2339.
23.
YoshiokaTKawazoeNTateishiT. In vitro evaluation of biodegradation of poly(lactic-co-glycolic acid) sponges. Biomaterials2008; 29(24–25): 3438–3443.
24.
Tahmasbi RadAAliNKotturiHSR. Conducting scaffolds for liver tissue engineering. J Biomed Mater Res A2014; 102(11): 4169–4181.
25.
PorterBOldhamJHeS-L. Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng2000; 122(3): 286–288.
26.
LvQNairLLaurencinCT. Fabrication, characterization, and in vitro evaluation of poly(lactic acid glycolic acid)/nano-hydroxyapatite composite microsphere-based scaffolds for bone tissue engineering in rotating bioreactors. J Biomed Mater Res A2009; 91(3): 679–691.
27.
YazdimamaghaniMRazaviMVashaeeD. Microstructural and mechanical study of PCL coated Mg scaffolds. Surf Eng2014; 30(12): 920–926.
KimHWLeeEJKimHE. Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity. Biomaterials2005; 26(21): 4395–4404.
30.
TahririMMoztarzadehF. Preparation, characterization, and in vitro biological evaluation of PLGA/nano-fluorohydroxyapatite (FHA) microsphere-sintered scaffolds for biomedical applications. Appl Biochem Biotechnol2014; 172(5): 2465–2479.
31.
AzamiMMoztarzadehFTahririM. Preparation, characterization and mechanical properties of controlled porous gelatin/hydroxyapatite nanocomposite through layer solvent casting combined with freeze-drying and lamination techniques. J Porous Mat2010; 17(3): 313–320.
32.
ZhangHChenZ. Fabrication and characterization of electrospun PLGA/MWNTs/hydroxyapatite biocomposite scaffolds for bone tissue engineering. J Bioact Compat Pol2010; 25: 241–259.
33.
MaXWuXHuY. Intervertebral spinal fusion using a RP-based PLGA/TCP/bBMP biomimetic grafting material. J Bioact Compat Pol2009; 24(Suppl. 1): 146–157.
34.
KhojastehAFahimipourFEslaminejadMB. Development of PLGA-coated β-TCP scaffolds containing VEGF for bone tissue engineering. Mater Sci Eng C2016; 69: 780–788.
35.
MozafariMMoztarzadehFRabieeM. Development of macroporous nanocomposite scaffolds of gelatin/bioactive glass prepared through layer solvent casting combined with lamination technique for bone tissue engineering. Ceram Int2010; 36(8): 2431–2439.
36.
RabieeSMNazparvarNAzizianM. Effect of ion substitution on properties of bioactive glasses: a review. Ceram Int2015; 41(6): 7241–7251.
37.
YazdimamaghaniMRazaviMVashaeeD. Surface modification of biodegradable porous Mg bone scaffold using polycaprolactone/bioactive glass composite. Mater Sci Eng C2015; 49: 436–444.
38.
GentilePChionoVCarmagnolaI. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci2014; 15(3): 3640–3659.
39.
KashiJSadatTMasaeliR. Preparation, characterization and evaluation of drug release properties of simvastatin loaded PLGA microspheres. Iran J Pharm Res2016; 205–211.
40.
NojehdehianHMoztarzadehFBaharvandH. Preparation and surface characterization of poly-L-lysine-coated PLGA microsphere scaffolds containing retinoic acid for nerve tissue engineering: in vitro study. Colloids Surf B2009; 73(1): 23–29.
41.
WangYShiXRenL. Poly(lactide-co-glycolide)/titania composite microsphere-sintered scaffolds for bone tissue engineering applications. J Biomed Mater Res B2010; 93(1): 84–92.
42.
EslamiHTahririMBakhshiF. Synthesis and characterization of nanocrystalline hydroxyapatite obtained by the wet chemical technique. Mater Sci Poland2010; 28(1): 5–13.
43.
TahririMSolati-HashjinMEslamiH. Synthesis and characterization of hydroxyapatite nanocrystals via chemical precipitation technique. Iran J Pharm Sci2008; 4(2): 127–134.
44.
RintoulLWentrup-ByrneESuzukiS. FT-IR spectroscopy of fluoro-substituted hydroxyapatite: strengths and limitations. J Mater Sci Mater M2007; 18(9): 1701–1709.
45.
EslamiHSolati-HashjinMTahririM. Synthesis and characterization of nanocrystalline fluorinated hydroxyapatite powder by modified wet-chemical process. J Ceram Process Res2008; 9: 224–229.
46.
JhaLJBestSMKnowlesJC. Preparation and characterization of fluoride-substituted apatites. J Mater Sci Mater M1997; 8(4): 185–191.
47.
SogoYItoAYokoyamaD. Synthesis of fluoride-releasing carbonate apatites for bone substitutes. J Mater Sci Mater M2007; 18(6): 1001–1007.
48.
ZhaoDWangYXuR. Composition-graded films of fluoroapatite/PHB fabricated via electrospinning for tissue engineering. J Bioact Compat Pol2007; 22(4): 379–393.
49.
EslamiHSolati-HashjinMTahririM. The comparison of powder characteristics and physicochemical, mechanical and biological properties between nanostructure ceramics of hydroxyapatite and fluoridated hydroxyapatite. Mater Sci Eng C2009; 29(4): 1387–1398.
50.
EslamiHSolati-HashjinMTahririM. Effect of fluorine ion addition on structural, thermal, mechanical, solubility and biocompatibility characteristics of hydroxyapatite nanopowders. Adv Appl Ceram Struct Funct Bioceram2010; 109(4): 200.
51.
NaikAShepherdDVShepherdJH. The effect of the type of HA on the degradation of PLGA/HA composites. Mater Sci Eng C2017; 70: 824–831.
52.
VertMLiSSpenlehauerG. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater M1992; 3(6): 432–446.
53.
YangZBestSMCameronRE. The influence of α-tricalcium phosphate nanoparticles and microparticles on the degradation of poly (D, L-lactide-co-glycolide). Adv Mater2009; 21(38–39): 3900–3904.
54.
LiHChangJ. pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA. Compos Sci Technol2005; 65(14): 2226–2232.
55.
YooJYKimJMSeoKS. Characterization of degradation behavior for PLGA in various pH condition by simple liquid chromatography method. Bio-Med Mater Eng2005; 15(4): 279–288.
56.
HouchinMToppE. Physical properties of PLGA films during polymer degradation. J Appl Polym Sci2009; 114(5): 2848–2854.
57.
SchillerCEppleM. Carbonated calcium phosphates are suitable pH-stabilising fillers for biodegradable polyesters. Biomaterials2003; 24(12): 2037–2043.
58.
KhanYMKattiDSLaurencinCT. Novel polymer-synthesized ceramic composite-based system for bone repair: an in vitro evaluation. J Biomed Mater Res A2004; 69(4): 728–737.
59.
LuXLengY. Theoretical analysis of calcium phosphate precipitation in simulated body fluid. Biomaterials2005; 26(10): 1097–1108.
60.
PrabhakarRLBrocchiniSKnowlesJC. Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass–polycaprolactone composites. Biomaterials2005; 26(15): 2209–2218.
61.
KriegerNSFrickKKBushinskyDA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hy2004; 13(4): 423–436.
62.
GodleyRStarosvetskyDGotmanI. Bonelike apatite formation on niobium metal treated in aqueous NaOH. J Mater Sci Mater M2004; 15(10): 1073–1077.
63.
DvorakMMRiccardiD. Ca2+ as an extracellular signal in bone. Cell Calcium2004; 35(3): 249–255.
64.
ShuRMcMullenRBaumannMJ. Hydroxyapatite accelerates differentiation and suppresses growth of MC3T3-E1 osteoblasts. J Biomed Mater Res A2003; 67(4): 1196–1204.
65.
JiangTAbdel-FattahWILaurencinCT. In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. Biomaterials2006; 27(28): 4894–4903.
66.
MakadiaHKSiegelSJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers2011; 3(3): 1377–1397.
67.
AkahaneMOhgushiHYoshikawaT. Osteogenic phenotype expression of allogeneic rat marrow cells in porous hydroxyapatite ceramics. J Bone Miner Res1999; 14(4): 561–568.
68.
OhgushiHDohiYTamaiS. Osteogenic differentiation of marrow stromal stem cells in porous hydroxyapatite ceramics. J Biomed Mater Res1993; 27(11): 1401–1407.
69.
NarayanRJ. The next generation of biomaterial development. Philos T Ser A Math Phys Eng Sci2010; 368(1917): 1831–1837.
70.
ZhangZKuritaHKobayashiH. Osteoinduction with HA/TCP ceramics of different composition and porous structure in rabbits. Oral Sci Int2005; 2(2): 85–95.
DvorakMMSiddiquaAWardDT. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A2004; 101(14): 5140–5145.
73.
YamaguchiTChattopadhyayNKiforO. Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+O)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res1998; 13(10): 1530–1538.
